Vera Therapeutics Inc’s recently made public that its Director ENRIGHT PATRICK G acquired Company’s shares for reported $4.37 million on Jun 23 ’25. In the deal valued at $20.87 per share,209,393 shares were bought. As a result of this transaction, ENRIGHT PATRICK G now holds 3,569,522 shares worth roughly $84.88 million.
Then, ENRIGHT PATRICK G bought 40,607 shares, generating $907,635 in total proceeds. Upon buying the shares at $22.35, the Director now owns 3,596,593 shares.
Before that, Fordyce Marshall sold 10,613 shares. Vera Therapeutics Inc shares valued at $296,032 were divested by the PRESIDENT AND CEO at a price of $27.89 per share. As a result of the transaction, Fordyce Marshall now holds 213,740 shares, worth roughly $5.08 million.
A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in early February with a ‘”an Outperform”‘ rating. Goldman began covering VERA with “Buy” recommendation on January 28, 2025. Wells Fargo started covering the stock on November 21, 2024. It rated VERA as “an Overweight”.
Price Performance Review of VERA
On Monday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock fall -0.17% to $23.78. Over the last five days, the stock has gained 3.53%. Vera Therapeutics Inc shares have fallen nearly -34.92% since the year began. Nevertheless, the stocks have fallen -43.77% over the past one year. While a 52-week high of $51.61 was reached on 01/06/25, a 52-week low of $18.53 was recorded on 04/09/25.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 23.52, which if violated will result in even more drops to 23.25. On the upside, there is a resistance level at 24.01. A further resistance level may holdings at 24.23.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2025-06-13, growing by 2.49 million shares to a total of 9.56 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 7.07 million shares. There was a rise of 26.06%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 16, 2024 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating .
